A comparative study on the effects of a monophasic pill containing desogestrel plus 20 μg ethinylestradiol, a triphasic combination containing levonorgestrel and a monophasic combination containing gestodene on coagulatory factors
- 31 January 1991
- journal article
- clinical trial
- Published by Elsevier in Contraception
- Vol. 43 (1) , 23-31
- https://doi.org/10.1016/0010-7824(91)90123-w
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Lipids, clotting factors, and diabetes: Endogenous risk factors for cardiovascular diseaseAmerican Journal of Obstetrics and Gynecology, 1988
- Oral contraceptives, lipids and cardiovascular diseaseContraception, 1985
- Fibrinopeptide a plasma levels during low-estrogen oral contraceptive treatmentContraception, 1984
- The effect of progestins in combined oral contraceptives on serum lipids with special reference to high-density lipoproteinsAmerican Journal of Obstetrics and Gynecology, 1982
- Progestogen Effects and their Relationship to Lipoprotein Changes: A Report from the Oral Contraception Study of the Royal College of General PractitionersActa Obstetricia et Gynecologica Scandinavica, 1982
- Oral Contraceptives and Cardiovascular DiseaseNew England Journal of Medicine, 1981
- Oral Contraceptives and Cardiovascular DiseaseNew England Journal of Medicine, 1981
- At III content and antithrombin activity in oestrogen-progestogen and progestogen-only treated womenThrombosis Research, 1980
- Progestogens and cardiovascular reactions associated with oral contraceptives and a comparison of the safety of 50- and 30-microgram oestrogen preparations.BMJ, 1980
- Thromboembolic Disease and the Steroidal Content of Oral Contraceptives. A Report to the Committee on Safety of DrugsBMJ, 1970